Bausch Health Companies (BHC) Net Cash Flow Growth (1y) (2010 - 2026)
Bausch Health Companies (BHC) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 112.26% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -44.11% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -236.85% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -1,047.81% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -1,020.00% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -807.00% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -107.45% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 444.33% |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn | 86.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.15% |
| Dec 31, 2025 | -104.53% |
| Sep 30, 2025 | -448.25% |
| Jun 30, 2025 | 544.72% |
| Mar 31, 2025 | 67.82% |
| Dec 31, 2024 | 198.16% |
| Sep 30, 2024 | -45.45% |
| Jun 30, 2024 | -319.64% |
| Mar 31, 2024 | -206.06% |
| Dec 31, 2023 | 158.73% |
| Sep 30, 2023 | 115.46% |
| Jun 30, 2023 | 109.91% |
| Mar 31, 2023 | -118.91% |
| Dec 31, 2022 | -71.23% |
| Sep 30, 2022 | -26,940.00% |
| Jun 30, 2022 | -1,469.44% |
| Mar 31, 2022 | 142.36% |
| Dec 31, 2021 | 213.47% |
| Sep 30, 2021 | -107.25% |
| Jun 30, 2021 | -80.00% |